Technical Analysis for MGTX - MeiraGTx Holdings plc

Grade	Last Price	% Change	Price Change
	15.44	6.78%	0.98

MGTX closed up 6.78 percent on Monday, November 11, 2019, on 70 percent of normal volume.

ADX	Long-Term	Intermediate-Term	Short-Term
Weak or Absent	Down	Down	Up
See historical MGTX trend table...

Date	Alert Name	Type	% Chg
Nov 11	Crossed Above 20 DMA	Bullish	0.00%
Nov 11	Stochastic Buy Signal	Bullish	0.00%
Nov 11	Bollinger Band Squeeze	Range Contraction	0.00%
Nov 11	BB Squeeze + Upper Band Touch	Range Contraction	0.00%
Nov 11	Up 3 Days in a Row	Strength	0.00%
Nov 11	Upper Bollinger Band Touch	Strength	0.00%
Nov 11	Oversold Stochastic	Weakness	0.00%
Nov 8	20 DMA Resistance	Bearish	6.78%
Nov 8	Bollinger Band Squeeze	Range Contraction	6.78%
Nov 8	Oversold Stochastic	Weakness	6.78%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

MeiraGTx Holdings PLC is a clinical stage gene therapy company. Its pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, West AMD, Dry AMD, and others. Geographically, the company generates a majority of its revenue from the United Kingdom.
Technology California Gene Therapy Macular Degeneration Gene Delivery Adeno Associated Virus AAV Advanced Micro Devices Pipeline Products

Indicator	Bull Case	Neutral / Hold	Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary:	Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Date	Title
Nov 7	MeiraGTx EPS beats by $0.23
Nov 7	MeiraGTx Reports Third Quarter 2019 Financial Results
Oct 28	Is MeiraGTx Holdings plc (MGTX) Going to Burn These Hedge Funds?
Oct 6	Key events this week - healthcare
Oct 3	MeiraGTx to Present at Upcoming Scientific and Investor Conferences
Sep 28	Stocks To Watch: Spotlight On Microsoft, Tesla And Xilinx
Sep 15	The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Sep 10	MeiraGTx To Present Clinical Data from Phase 1/2 Trial of AAV-RPE65 at Upcoming Scientific Conferences
Sep 3	Sell-siders like InMode in premarket analyst action
Aug 15	Could MeiraGTx Holdings plc's (NASDAQ:MGTX) Investor Composition Influence The Stock Price?

Pivot Point Level	Traditional / Classic	Fibonacci	Demark	Woodie	Camarilla
Resistance 4 (R4)					17.68
Resistance 3 (R3)	17.54	16.65			17.30
Resistance 2 (R2)	16.65	16.08		16.72	17.18
Resistance 1 (R1)	16.05	15.73	16.35	16.19	17.05
Pivot Point	15.16	15.16	15.32	15.23	15.16
Support 1 (S1)	14.56	14.59	14.86	14.70	13.83
Support 2 (S2)	13.67	14.24		13.74	13.70
Support 3 (S3)	13.07	13.67			13.58
Support 4 (S4)					13.21